MSB 2.58% 94.5¢ mesoblast limited

from teva's website

  1. 497 Posts.
    lightbulb Created with Sketch. 3
    I was scratching around on TEVA'S website and found this, it may have already been posted.

    Teva's future drugs

    Revascor for heart failure, from Australian company Mesoblast which produces drugs based on stem cells. The drug could yield sales of $2 billion a year. Teva is financing the trials, currently in phase 2, in exchange for royalties


    Do Your Own Research

    Good Luck Holders
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
94.5¢
Change
-0.025(2.58%)
Mkt cap ! $1.078B
Open High Low Value Volume
98.0¢ 98.5¢ 94.0¢ $2.482M 2.602M

Buyers (Bids)

No. Vol. Price($)
6 71720 94.0¢
 

Sellers (Offers)

Price($) Vol. No.
94.5¢ 10463 1
View Market Depth
Last trade - 16.10pm 06/09/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.